Skip to main content
Coloplast A/S (CLPBF)
OTCMKTS · Delayed Price · Currency is USD
123.01
-1.59 (-1.28%)
Nov 18, 2024, 4:00 PM EST

Coloplast Revenue

In the fiscal year ending September 30, 2024, Coloplast had annual revenue of 27.03B DKK with 10.33% growth. Coloplast had revenue of 6.95B in the quarter ending September 30, 2024, with 11.68% growth.

Revenue
27.03B DKK
Revenue Growth
+10.33%
P/S Ratio
n/a
Revenue / Employee
1.62M DKK
Employees
16,639
Market Cap
27.64B USD

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Sep 30, 202427.03B2.53B10.33%
Sep 30, 202324.50B1.92B8.51%
Sep 30, 202222.58B3.15B16.23%
Sep 30, 202119.43B882.00M4.76%
Sep 30, 202018.54B605.00M3.37%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sandoz Group AG 10.11B
Telix Pharmaceuticals Limited 430.80M
Elekta AB (publ) 1.69B
Ryman Healthcare Limited 411.39M
Verano Holdings Corp. 897.57M
Vireo Growth Inc. 98.53M
Medexus Pharmaceuticals Inc. 104.76M
Revenue Rankings

Coloplast News

More News